Epidemiology, health policy and outcomes
Eric Dein, MD, RhMSUS
Institute of Rheumatic and Autoimmune Diseases, Overlook Hospital
Jersey City, NJ, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Louisa Ziglar, MD
Arthritis & Rheumatism Associates PC
Rockville, MD, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Whether it’s frustrations with the soaring prices of drugs, hassling with payers and PBMs, or just feeling overwhelmed from the sheer volume of patients you see each day, it’s incredibly easy to feel like nothing will change.
Learn what ACR advocacy efforts are doing to help channel those frustrations into actionable results that benefit you and your patients. While progress is incremental, learn more about the changing landscape and how the narrative has begun to shift regarding some of the issues you face most frequently:
- Rising Price of Drugs/Dealing with PBMs
- Issues with Payers and Utilization Management Tactics
- Workforce Shortage
Have other issues or specific questions about what the ACR is doing for you in the advocacy space? Come join us for an open Q&A to raise those concerns and see what the ACR may already be doing.
Speaker: E. Blair Solow, MD, MSc – UT Southwestern Medical Center
Speaker: Lennie McDaniel, JD – American College of Rheumatology
Speaker: Angus Worthing, MD – Arthritis & Rheumatism Associates, PC
Speaker: Howard Blumstein, MD – Rheumatology Associates of Long Island
